These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 1647426

  • 21. Enzyme-linked immunosorbent assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigen.
    Dölken G, Weitzmann U, Boldt C, Bitzer M, Brugger W, Löhr GW.
    J Immunol Methods; 1984 Mar 16; 67(2):225-33. PubMed ID: 6323578
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Possible involvement of Epstein-Barr virus (EBV) in polyclonal B-cell activation in Sjögren's syndrome.
    Miyasaka N, Yamaoka K, Tateishi M, Nishioka K, Yamamoto K.
    J Autoimmun; 1989 Aug 16; 2(4):427-32. PubMed ID: 2551309
    [Abstract] [Full Text] [Related]

  • 24. Epstein-Barr virus and the lacrimal gland pathology of Sjögren's syndrome.
    Pflugfelder SC, Crouse CA, Monroy D, Yen M, Rowe M, Atherton SS.
    Am J Pathol; 1993 Jul 16; 143(1):49-64. PubMed ID: 8391219
    [Abstract] [Full Text] [Related]

  • 25. [What is the role of Epstein-Barr virus in the pathogenesis of connective tissue diseases?].
    Sany J.
    Presse Med; 1987 Apr 25; 16(15):725-8. PubMed ID: 3033628
    [Abstract] [Full Text] [Related]

  • 26. [Renal tubular acidosis in primary Sjogren's syndrome: study on the immunology and ultrastructure of EBV].
    He ZG.
    Zhonghua Bing Li Xue Za Zhi; 1991 Dec 25; 20(4):268-70. PubMed ID: 1667508
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Development of a recombinant enzyme-linked immunosorbent assay for detection of antibodies against Epstein-Barr virus nuclear antigens 2A and 2B.
    Geertsen R, Espander-Jansson A, Dobec M, Price P, Wunderli W, Rymo L.
    J Clin Microbiol; 1994 Jan 25; 32(1):112-20. PubMed ID: 8126164
    [Abstract] [Full Text] [Related]

  • 29. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis.
    Sculley TB, Pope JH, Hazelton RA.
    Arthritis Rheum; 1986 Aug 25; 29(8):964-70. PubMed ID: 3017369
    [Abstract] [Full Text] [Related]

  • 30. Normal serologic response to Epstein-Barr virus in patients with Sjögren's syndrome.
    Venables PJ, Baboonian C, Maini RN.
    Arthritis Rheum; 1989 Jun 25; 32(6):811-2. PubMed ID: 2544190
    [No Abstract] [Full Text] [Related]

  • 31. Epstein-Barr virus as an etiological agent in primary Sjögren's syndrome.
    Whittingham S, McNeilage LJ, Mackay IR.
    Med Hypotheses; 1987 Apr 25; 22(4):373-86. PubMed ID: 3035352
    [Abstract] [Full Text] [Related]

  • 32. Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjögren's syndrome.
    Venables PJ, Teo CG, Baboonian C, Griffin BE, Hughes RA.
    Clin Exp Immunol; 1989 Mar 25; 75(3):359-64. PubMed ID: 2539280
    [Abstract] [Full Text] [Related]

  • 33. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis.
    Alspaugh MA, Henle G, Lennette ET, Henle W.
    J Clin Invest; 1981 Apr 25; 67(4):1134-40. PubMed ID: 6259211
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis.
    Linde A, Kallin B, Dillner J, Andersson J, Jägdahl L, Lindvall A, Wahren B.
    J Infect Dis; 1990 May 25; 161(5):903-9. PubMed ID: 2157771
    [Abstract] [Full Text] [Related]

  • 35. Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjögren's syndrome.
    Yamaoka K, Miyasaka N, Yamamoto K.
    Arthritis Rheum; 1988 Aug 25; 31(8):1014-21. PubMed ID: 2841943
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW, Myrmel H.
    J Clin Virol; 2007 Apr 25; 38(4):292-7. PubMed ID: 17336144
    [Abstract] [Full Text] [Related]

  • 37. Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera.
    Kouri T, Petersen J, Rhodes G, Aho K, Palosuo T, Heliövaara M, Isomäki H, von Essen R, Vaughan JH.
    J Rheumatol; 1990 Nov 25; 17(11):1442-9. PubMed ID: 2177109
    [Abstract] [Full Text] [Related]

  • 38. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus.
    Kitagawa H, Iho S, Yokochi T, Hoshino T.
    Immunol Lett; 1988 Mar 25; 17(3):249-52. PubMed ID: 2836302
    [Abstract] [Full Text] [Related]

  • 39. A novel EBV-related nucleo-cytoplasmic antigen in a null cell-line (HLN-STL-C) reactive to antibodies in the sera from patients with Sjögren's syndrome.
    Nagasaki M, Morikawa S, Harada T, Miyasaka N.
    J Autoimmun; 1989 Aug 25; 2(4):457-62. PubMed ID: 2551312
    [Abstract] [Full Text] [Related]

  • 40. Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency.
    Pflugfelder SC, Tseng SC, Pepose JS, Fletcher MA, Klimas N, Feuer W.
    Ophthalmology; 1990 Mar 25; 97(3):313-23. PubMed ID: 2159609
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.